Live From

Interphex

April 1 - 3, 2025
|
New York, NY
Sponsored By
Interphex

Alcami Introduces OnDemand Customer Portal Application

Aims to allow clients rapid access and visualization into their ongoing projects

Alcami, a provider of development and manufacturing services for the pharma and biopharma industries, has launched its new customer portal and mobile application: Alcami OnDemand. The initial phase will concentrate on the sample submission process within its Analytical Testing offering.
 
The new customer portal is designed to allow Alcami’s clients and prospects rapid access and visualization into their ongoing projects. The portal will serve as a single source for customer project and order management with shared views to manage orders, libraries of compounds, test results and accounting information.
 
“The new system addresses the un-met market need for a simplified sample submission process, real-time tracking of sample submissions and projects, customer access to historical data and transparency,” said chief commercial officer, Syed T. Husain. “Alcami OnDemand is another exciting first to market initiative that allows us to provide a personalized customer experience to the Pharma & Biotech industry.”
 
The dashboard provides straightforward, intuitive controls that allow for quick and efficient completion of tasks, according to the company. Customer information is pre-populated to help reduce data entry requirements. The system also provides user prompts based on real-time project data. Customers have access to historical order information and reporting data, as well as snapshot views of the status of their projects with real-time updates.
 
The Customer Portal will launch first in April 2017 with beta testing for submission of samples by a selected group of existing analytical testing customers. Launch of the application to new customers will take place in June 2017. Alcami plans to expand the application across its API and Drug Product manufacturing and Development Services platforms throughout 2017 and 2018.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters